SurModics (SRDX) Tops Q4 EPS by 17c; Provides Mixed Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. USO
3. BBIO
4. SPY
5. NVDA
6. OPCH
7. SKYD
8. GOOGL
9. AMD
10. CHRW

Go back to SurModics (SRDX) Tops Q4 EPS by 17c; Provides Mixed Guidance

Surmodics Reports Fourth Quarter Fiscal 2016 Results

November 16, 2016 7:30 AM EST

GAAP Revenue of $18.2 Million, up 5% GAAP EPS of $0.20, Non-GAAP EPS of $0.26 Core Business Performs Well as Key Strategic Growth Priorities Advance Fiscal 2017 Revenue and EPS Guidance Outlined

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2016 fourth quarter, ended September 30, 2016.

The fourth quarter marked the continuation of the... More